1,25-dihydroxyvitamin D in malignant and non-malignant pleural effusions

M. Panagiotou, A. I. Papaioannou, F. Diamantea, S. Giannakaki, E. M. Antonogiannaki, S. Pouriki, A. Kalkanis, A. Takou, G. D. Maropoulos, E. Kastanakis, V. Polychronopoulos, K. Kostikas, N. Karagianidis (Athens, Greece)

Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Session: Clinical problems in mediastinal and pleural malignacies
Session type: Poster Discussion
Number: 3080
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Panagiotou, A. I. Papaioannou, F. Diamantea, S. Giannakaki, E. M. Antonogiannaki, S. Pouriki, A. Kalkanis, A. Takou, G. D. Maropoulos, E. Kastanakis, V. Polychronopoulos, K. Kostikas, N. Karagianidis (Athens, Greece). 1,25-dihydroxyvitamin D in malignant and non-malignant pleural effusions. Eur Respir J 2013; 42: Suppl. 57, 3080

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association of biochemical determinants and fibrinous formation in malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

High fluorescence cells in pleural fluid. Association with pleural malignancy
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013


Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016

Non-malignant pleural disease from asbestos and malignant pleural mesothelioma
Source: Eur Respir Monogr 2020; 89: 141-149
Year: 2020


Management of malignant pleural effusions
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019

Management of malignant pleural effusions
Source: Guideline 2001
Year: 2001

Management of malignant pleural effusions
Source: Eur Respir J 2001; 18: 402-419
Year: 2001


Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013

Management of malignant pleural mesothelioma
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016

Management of malignant pleural mesothelioma
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012

Management of malignant pleural mesothelioma
Source: ERS Skills Course 2015
Year: 2015

Management of malignant pleural mesothelioma
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014

Diagnosis of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004

Role of fibulin-3 in the diagnosis of malignant mesothelioma
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014